These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
4. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
5. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
6. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394 [TBL] [Abstract][Full Text] [Related]
9. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083 [TBL] [Abstract][Full Text] [Related]
11. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523 [TBL] [Abstract][Full Text] [Related]
12. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. More H; Humar B; Weber W; Ward R; Christian A; Lintott C; Graziano F; Ruzzo AM; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P Hum Mutat; 2007 Feb; 28(2):203. PubMed ID: 17221870 [TBL] [Abstract][Full Text] [Related]
13. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427 [TBL] [Abstract][Full Text] [Related]
14. CDH1 associated gastric cancer: a report of a family and review of the literature. Moran CJ; Joyce M; McAnena OJ Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560 [TBL] [Abstract][Full Text] [Related]
15. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer]. de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213 [TBL] [Abstract][Full Text] [Related]
16. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Pinheiro H; Oliveira C; Seruca R; Carneiro F Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071 [TBL] [Abstract][Full Text] [Related]
17. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658 [TBL] [Abstract][Full Text] [Related]
18. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293 [TBL] [Abstract][Full Text] [Related]
19. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422 [TBL] [Abstract][Full Text] [Related]
20. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Grady WM; Willis J; Guilford PJ; Dunbier AK; Toro TT; Lynch H; Wiesner G; Ferguson K; Eng C; Park JG; Kim SJ; Markowitz S Nat Genet; 2000 Sep; 26(1):16-7. PubMed ID: 10973239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]